Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289626 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Lanthanum Carbonate in Calciphylaxis
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01289626 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants.
The verdict
NCT01289626, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The research question and primary aim is to determine if lanthanum carbonate is effective in treating calciphylaxis by measurement of complete or partial remission of skin lesions. Secondary endpoints will be measured to determine if lanthanum carbonate can lower calcium-phosphorus product levels, intact PTH and mortality. Albumin levels will be measured as a marker of nutritional status and inflammation.
Interventions
- DRUG lanthanum carbonate
- DRUG Lanthanum for calciphylaxis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01289626
The ClinicalTrials.gov registry entry for NCT01289626 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lanthanum carbonate is the first listed.
NCT01289626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01289626 about?
NCT01289626 is a clinical study titled "Efficacy of Lanthanum Carbonate in Calciphylaxis". The research question and primary aim is to determine if lanthanum carbonate is effective in treating calciphylaxis by measurement of complete or partial remission of skin lesions. Secondary endpoints will be measured to determine if lanthanum carbonate can lower calcium-phosphorus product levels, i...
What is the current status of trial NCT01289626?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01289626?
The interventions under investigation include: lanthanum carbonate (DRUG), Lanthanum for calciphylaxis (DRUG).
Who is sponsoring clinical trial NCT01289626?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.